Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Mark  Gaydos

Mark Gaydos

Head of Labeling and Advertising & Promotion, Global Regulatory Science

Moderna, United States

Learning Objective : Discuss the types of information companies might consider communicating in the pre-approval phase; Identify the communications pros and cons in the pre-approval phase.

Speaker(s)

Mark  Gaydos

Enforcement Action Summary

Mark Gaydos

Moderna, United States

Head of Labeling and Advertising & Promotion, Global Regulatory Science

Dennis Lawrence Nosco, PHD, RAC

Emerging Communication Channels in Preapproval Communication: Does the Medium Matter?

Dennis Lawrence Nosco, PHD, RAC

Mallinckrodt, United States

Senior Director, Global Labeling, Regulatory Affairs

Alan R Bennett, JD

Impact of Caronia on Preapproval Communications

Alan R Bennett, JD

Ropes & Gray, United States

Senior Counsel

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.